Area of research
Oncology · Genetics
Research interest
Research interests include CAR-T cell therapy research, Virus-based gene therapy research, Hematopoietic Stem Cell Transplantation, and Acute Lymphoblastic Leukemia research.
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients
Mediport use as an acceptable standard for CAR T cell infusion
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome
Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference
Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
β-globin gene transfer to human bone marrow for sickle cell disease
Hematopoietic stem cells for cancer immunotherapy